ArticleCancer science2020

Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer.

Yoon-Sim Yap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.